{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:38:22Z","timestamp":1784266702114,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.108921","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T12:35:41Z","timestamp":1655469341000},"page":"108921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Angiotensin II type 2 receptor pharmacological agonist, C21, reduces the inflammation and pain hypersensitivity in mice with joint inflammatory pain"],"prefix":"10.1016","volume":"110","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-dan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qing","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-shan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2022.108921_b0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11914-015-0291-y","article-title":"A Mechanism-Based Approach to the Management of Osteoarthritis Pain","volume":"13","author":"Cohen","year":"2015","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"10.1016\/j.intimp.2022.108921_b0010","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1016\/j.arth.2018.07.028","article-title":"Predictive Factors for Developing Chronic Pain After Total Knee Arthroplasty","volume":"33","author":"Kim","year":"2018","journal-title":"J Arthroplasty"},{"issue":"3","key":"10.1016\/j.intimp.2022.108921_b0015","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.pain.2008.01.020","article-title":"Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice","volume":"137","author":"Ikeuchi","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.intimp.2022.108921_b0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/j.1532-2149.2012.00223.x","article-title":"Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl\/6 mice","volume":"17","author":"Ogbonna","year":"2013","journal-title":"Eur J Pain"},{"issue":"6","key":"10.1016\/j.intimp.2022.108921_b0025","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/art.39082","article-title":"Calcitonin gene-related peptide-expressing sensory neurons and spinal microglial reactivity contribute to pain states in collagen-induced arthritis","volume":"67","author":"Nieto","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/annrheumdis-2015-208886","article-title":"Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation","volume":"76","author":"Alawi","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.intimp.2022.108921_b0035","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/art.21040","article-title":"Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice","volume":"52","author":"Sagawa","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.intimp.2022.108921_b0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.22335","article-title":"Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis","volume":"56","author":"Price","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.intimp.2022.108921_b0045","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/ard.2007.082917","article-title":"Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis","volume":"67","author":"Perry","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.intimp.2022.108921_b0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11916-012-0303-x","article-title":"Pain in rheumatoid arthritis","volume":"16","author":"Walsh","year":"2012","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"10.1016\/j.intimp.2022.108921_b0055","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.40428","article-title":"Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data","volume":"70","author":"Orange","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.intimp.2022.108921_b0060","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jcmm.12128","article-title":"Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis","volume":"17","author":"Wang","year":"2013","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0065","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1038\/s41598-017-13746-w","article-title":"Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium","volume":"7","author":"Terenzi","year":"2017","journal-title":"Sci Rep"},{"issue":"9929","key":"10.1016\/j.intimp.2022.108921_b0070","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(13)62337-5","article-title":"E.M.A.s. group, EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"383","author":"Rice","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.intimp.2022.108921_b0075","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/j.1532-2149.2012.00269.x","article-title":"Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons","volume":"17","author":"Anand","year":"2013","journal-title":"Eur J Pain"},{"issue":"10","key":"10.1016\/j.intimp.2022.108921_b0080","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/pme.12157","article-title":"A small molecule angiotensin II type 2 receptor (AT(2)R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44\/p42 MAPK activation in the dorsal root ganglia","volume":"14","author":"Smith","year":"2013","journal-title":"Pain Med"},{"key":"10.1016\/j.intimp.2022.108921_b0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12990-015-0038-x","article-title":"Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies","volume":"11","author":"Anand","year":"2015","journal-title":"Mol Pain"},{"issue":"7","key":"10.1016\/j.intimp.2022.108921_b0090","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.cell.2014.04.040","article-title":"Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways","volume":"157","author":"Marion","year":"2014","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2022.108921_b0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/toxins9070227","article-title":"A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone","volume":"9","author":"Song","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"12","key":"10.1016\/j.intimp.2022.108921_b0100","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1097\/j.pain.0000000000001361","article-title":"Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia","volume":"159","author":"Bessaguet","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2022.108921_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fnmol.2017.00389","volume":"10","author":"Khan","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"10.1016\/j.intimp.2022.108921_b0110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jpain.2016.12.008","article-title":"A Local Inflammatory Renin-Angiotensin System Drives Sensory Axon Sprouting in Provoked Vestibulodynia","volume":"18","author":"Liao","year":"2017","journal-title":"J Pain"},{"issue":"3","key":"10.1016\/j.intimp.2022.108921_b0115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jpain.2017.10.006","article-title":"Inflammatory Renin-Angiotensin System Disruption Attenuates Sensory Hyperinnervation and Mechanical Hypersensitivity in a Rat Model of Provoked Vestibulodynia","volume":"19","author":"Chakrabarty","year":"2018","journal-title":"J Pain"},{"issue":"32","key":"10.1016\/j.intimp.2022.108921_b0120","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1523\/JNEUROSCI.3542-17.2018","article-title":"Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain","volume":"38","author":"Shepherd","year":"2018","journal-title":"J Neurosci"},{"issue":"34","key":"10.1016\/j.intimp.2022.108921_b0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1721815115","article-title":"Macrophage angiotensin II type 2 receptor triggers neuropathic pain","volume":"115","author":"Shepherd","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.intimp.2022.108921_b0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.joca.2021.11.014","article-title":"Joint synovial macrophages as a potential target for intra-articular treatment of osteoarthritis-related pain","volume":"30","author":"Wang","year":"2022","journal-title":"Osteoarthr Cartilage"},{"issue":"9","key":"10.1016\/j.intimp.2022.108921_b0135","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.joca.2016.04.010","article-title":"Direct in vivo evidence of activated macrophages in human osteoarthritis","volume":"24","author":"Kraus","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"10.1016\/j.intimp.2022.108921_b0140","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/art.39488","article-title":"Association of Joint Inflammation With Pain Sensitization in Knee Osteoarthritis: The Multicenter Osteoarthritis Study","volume":"68","author":"Neogi","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.intimp.2022.108921_b0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/j.pain.0000000000001466","article-title":"Contribution of synovial macrophages to rat advanced osteoarthritis pain resistant to cyclooxygenase inhibitors","volume":"160","author":"Sakurai","year":"2019","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.intimp.2022.108921_b0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nbd.2007.02.007","article-title":"Is functional state of spinal microglia involved in the anti-allodynic and anti-hyperalgesic effects of electroacupuncture in rat model of monoarthritis?","volume":"26","author":"Shan","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.intimp.2022.108921_b0155","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.joca.2016.09.007","article-title":"Spinal microglial activation in a murine surgical model of knee osteoarthritis","volume":"25","author":"Tran","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/j.pain.0000000000001394","article-title":"Exploring the transcriptome of resident spinal microglia after collagen antibody-induced arthritis","volume":"160","author":"Fernandez-Zafra","year":"2019","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.intimp.2022.108921_b0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11926-021-00997-w","article-title":"Involvement of Macrophages and Spinal Microglia in Osteoarthritis Pain","volume":"23","author":"Pan","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.intimp.2022.108921_b0170","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/art.30150","article-title":"A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor alpha-induced inflammatory hyperalgesia and Freund's complete adjuvant-induced monarthritis","volume":"63","author":"Fernandes","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.intimp.2022.108921_b0175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.joca.2012.01.005","article-title":"Anti-inflammatory effect of low intensity ultrasound (LIUS) on complete Freund's adjuvant-induced arthritis synovium","volume":"20","author":"Chung","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneumeth.2007.02.012","article-title":"Pressure application measurement (PAM): a novel behavioural technique for measuring hypersensitivity in a rat model of joint pain","volume":"163","author":"Barton","year":"2007","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.intimp.2022.108921_b0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbr.2014.02.003","article-title":"Amitriptyline reverses hyperalgesia and improves associated mood-like disorders in a model of experim ental monoarthritis","volume":"265","author":"Amorim","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.intimp.2022.108921_b0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2474-14-14","article-title":"Gait analysis of C57BL\/6 mice with complete Freund's adjuvant-induced arthritis using the CatWalk system","volume":"14","author":"Parvathy","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.intimp.2022.108921_b0195","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroscience.2019.05.034","article-title":"Microglia in the Primary Somatosensory Barrel Cortex Mediate Trigeminal Neuropathic Pain","volume":"414","author":"Wang","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2022.108921_b0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-6606-5-18","article-title":"Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats","volume":"5","author":"Yang","year":"2012","journal-title":"Mol Brain"},{"issue":"2","key":"10.1016\/j.intimp.2022.108921_b0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1470320312467557","article-title":"Developmental expression patterns for angiotensin receptors in mouse skin and brain","volume":"15","author":"Yu","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3","key":"10.1016\/j.intimp.2022.108921_b0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1470320312443720","article-title":"Ontogeny of angiotensin type 2 and type 1 receptor expression in mice","volume":"13","author":"Gao","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"6","key":"10.1016\/j.intimp.2022.108921_b0215","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.112.199646","article-title":"Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats","volume":"60","author":"McCarthy","year":"2012","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.intimp.2022.108921_b0220","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2022.108921_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20130601","article-title":"Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice","volume":"128","author":"Valero-Esquitino","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.intimp.2022.108921_b0230","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1007\/s12035-018-1272-9","article-title":"AT2R Activation Prevents Microglia Pro-inflammatory Activation in a NOX-Dependent Manner: Inhibition of PKC Activation and p47(phox) Phosphorylation by PP2A","volume":"56","author":"Bhat","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.intimp.2022.108921_b0235","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12975-019-00752-5","article-title":"Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization","volume":"11","author":"Jackson","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.intimp.2022.108921_b0240","article-title":"Compound 21, a Direct AT2R Agonist, Induces IL-10 and Inhibits Inflammation in Mice Following Traumatic Brain Injury","author":"Ismael","year":"2021","journal-title":"Neuromolecular Med"},{"issue":"11","key":"10.1016\/j.intimp.2022.108921_b0245","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.4049\/jimmunol.2000561","article-title":"Angiotensin II Type 2 Receptor Modulates Synovial Macrophage Polarization by Inhibiting GRK2 Membrane Translocation in a Rat Model of Collagen-Induced Arthritis","volume":"205","author":"Wang","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2022.108921_b0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-8069-4-15","article-title":"Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse","volume":"4","author":"Zhang","year":"2008","journal-title":"Mol Pain"},{"issue":"6","key":"10.1016\/j.intimp.2022.108921_b0255","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0260","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12974-016-0556-0","article-title":"Neuron-immune mechanisms contribute to pain in early stages of arthritis","volume":"13","author":"Nieto","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.intimp.2022.108921_b0265","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","article-title":"NF-kappaB Signaling in Macrophages: Dynamics","volume":"10","author":"Dorrington","year":"2019","journal-title":"Crosstalk, and Signal Integration, Front Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1043-2760(99)00205-2","article-title":"Signal transduction from the angiotensin II AT2 receptor","volume":"11","author":"Nouet","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.intimp.2022.108921_b0275","doi-asserted-by":"crossref","first-page":"R1461","DOI":"10.1152\/ajpregu.00014.2007","article-title":"NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats","volume":"293","author":"Siragy","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0280","doi-asserted-by":"crossref","first-page":"e892","DOI":"10.1097\/PR9.0000000000000892","article-title":"Neuroimmune interactions and osteoarthritis pain: focus on macrophages","volume":"6","author":"Geraghty","year":"2021","journal-title":"Pain Rep"},{"key":"10.1016\/j.intimp.2022.108921_b0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.conb.2019.11.006","article-title":"Regulation of pain by neuro-immune interactions between macrophages and nociceptor sensory neurons","volume":"62","author":"Chen","year":"2020","journal-title":"Curr Opin Neurobiol"},{"issue":"10","key":"10.1016\/j.intimp.2022.108921_b0290","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2018-213450","article-title":"Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2","volume":"77","author":"Zhang","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.intimp.2022.108921_b0295","first-page":"2006","article-title":"Modulators of microglia activation and polarization in ischemic stroke (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.intimp.2022.108921_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.571994","article-title":"Angiotensin Type 2 Receptors: Painful, or Not?","volume":"11","author":"Pulakat","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2022.108921_b0305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/pme.12258","article-title":"Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain","volume":"15","author":"Muralidharan","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.intimp.2022.108921_b0310","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbi.2021.12.021","article-title":"Glutamatergic neurons and myeloid cells in the anterior cingulate cortex mediate secondary hyperalgesia in chronic joint inflammatory pain","volume":"101","author":"Pan","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2022.108921_b0315","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.intimp.2022.108921_b0320","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/glia.10037","article-title":"Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS","volume":"37","author":"Hughes","year":"2002","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.intimp.2022.108921_b0325","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jpain.2013.04.002","article-title":"Angiotensin II receptor type 2 activation is required for cutaneous sensory hyperinnervation and hypersensitivity in a rat hind paw model of inflammatory pain","volume":"14","author":"Chakrabarty","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.intimp.2022.108921_b0330","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.peptides.2012.11.011","article-title":"The role of the angiotensin AT2 receptor on the diurnal variations of nociception and motor coordination in rats","volume":"39","author":"Pechlivanova","year":"2013","journal-title":"Peptides"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922004052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922004052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:47:46Z","timestamp":1761587266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922004052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":66,"alternative-id":["S1567576922004052"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108921","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II type 2 receptor pharmacological agonist, C21, reduces the inflammation and pain hypersensitivity in mice with joint inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108921"}}